AI Article Synopsis
- Utilized various molecular platforms, the study evaluated extraction and PCR assays for detecting SARS-CoV-2 in 65 positive samples, utilizing different extraction techniques and testing methods.* * Results highlighted that viral RNA extracted using the MagNA Pure system showed lower median Ct values compared to another extraction method (EpMotion), indicating a more effective extraction process.* * Additionally, the study compared commercial assays to laboratory-developed tests, showing that certain commercial options provided lower median Ct values, suggesting they might be more sensitive in detecting the virus.*
Article Abstract
Utilising diverse molecular platforms has formed a solid foundation in New Zealand's COVID-19 response. We evaluated multiple extraction and PCR assays for the detection of SARS-CoV-2. We included 65 positive samples which were run on the Panther Fusion using a laboratory developed test (LDT, E gene target). Where viral RNA was extracted by MagNA Pure (MP) 96 extraction platform or EpMotion 5075/Geneaid extraction kit, SARS-CoV-2 detection was performed on Light Cycler (LC) 480 using a LDT (E gene) or 3 commercial assays; Certest Viasure (Orf1ab, N genes) GenePro (E, RdRp genes) and A* Star Fortitude (proprietary target). Median Cts on LC 480 LDT for specimens (n = 9) extracted on MP 96 (26.6) were lower than on EpMotion (31.6) whereas median Cts for specimens (n = 10) extracted on the Panther Fusion LDT (23.1) were comparable with MP 96 /LC480 LDT (23.6). Specimens tested on Panther Fusion LDT (n = 28), extracted by MP 96, and amplified using commercial assays showed good concordance with a few exceptions; lower median Ct values were seen for 2 targets on GenePro (16.9, 21.5) and Viasure (19.5, 21.1) than for the Panther Fusion LDT (24.2) and A* Star Fortitude (25.6). Specimens tested on MP 96 (n = 18) had comparable results using commercial assays, with lower median Cts for Viasure (22.2, 23.7) compared with the LC 480 LDT (24.7), GenePro (24.7,25.7) and A*Fortitude (25.1) assays. The study provides an early assessment of the performance characteristics of 3 extraction methods for viral RNA and 5 PCR assays for the detection of SARS-CoV-2.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837327 | PMC |
| http://dx.doi.org/10.1016/j.jviromet.2020.114042 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Improved costs and turnaround time for Treponema pallidum detection utilising a real-time PCR assay developed for the Hologic Panther Fusion system.
Pathology
November 2024
Virology and Immunology Department, Labplus, Auckland City Hospital, Te Toka Tumai Auckland, Health New Zealand, New Zealand. Electronic address:
The aims of this study were to evaluate the performance and workflow characteristics of a laboratory-developed test to detect Treponema pallidum on the Hologic Panther Fusion system compared with an existing commercial assay. A Hologic Panther Fusion-based real-time polymerase chain reaction assay was optimised for T. pallidum (TP RT-PCR) using previously published primer and probe sequences and validated with a simplified preprocessing protocol.
View Article and Find Full Text PDFAn automated commercial open access assay for detection of Mycoplasma genitalium macrolide resistance.
APMIS
January 2025
Clinical Microbiology, Infection Prevention and Control, Office for Medical Services, Lund, Sweden.
Article Synopsis
- Azithromycin is the main antibiotic used to treat Mycoplasma genitalium (MG), but resistance due to mutations is becoming a concern, particularly in the 23S rRNA gene.
- A study evaluated the Panther Fusion analyzer for detecting macrolide resistance mutations (MRM) and wild type (WT) MG in clinical samples, finding a 91% agreement with an established PCR method.
- The Panther Fusion detected MRM in 20% and WT in 62% of samples, showing potential for easier testing but slightly lower effectiveness for macrolide susceptibility testing, suggesting the need for additional testing methods when results are unclear.
Anti-VEGF Pharmaceutical Prior Authorization in Retina Practices.
JAMA Ophthalmol
August 2024
Retina Consultants of Texas, Houston.
Importance: Anti-vascular endothelial growth factor (VEGF) intravitreal injections, a mainstay of treatment for many retinal diseases to optimize visual outcomes, have been included in prior authorization (PA) initiatives. However, if clinicians are extremely accurate in their use of anti-VEGF medications, such administrative burdens may need reconsideration.
Objective: To quantify PA for anti-VEGF medications (aflibercept, ranibizumab, and bevacizumab) that were approved and determine associated administrative burdens experienced by retina practices.
Torquetenovirus Viremia Quantification Using Real-Time PCR Developed on a Fully Automated, Random-Access Platform.
Viruses
June 2024
Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.
Quantification of Torquetenovirus (TTV) viremia is becoming important for evaluating the status of the immune system in solid organ transplant recipients, monitoring the appearance of post-transplant complications, and controlling the efficacy of maintenance immunosuppressive therapy. Thus, diagnostic approaches able to scale up TTV quantification are needed. Here, we report on the development and validation of a real-time PCR assay for TTV quantification on the Hologic Panther Fusion System by utilizing its open-access channel.
View Article and Find Full Text PDFHuman MuStem cells are competent to fuse with nonhuman primate myofibers in a clinically relevant transplantation context: A proof-of-concept study.
J Neuropathol Exp Neurol
August 2024
Oniris, INRAE, PAnTher, Nantes, France.
We previously reported that human muscle-derived stem cells (hMuStem cells) contribute to tissue repair after local administration into injured skeletal muscle or infarcted heart in immunodeficient rodent models. However, extrapolation of these findings to a clinical context is problematic owing to the considerable differences often seen between in vivo findings in humans versus rodents. Therefore, we investigated whether the muscle regenerative behavior of hMuStem cells is maintained in a clinically relevant transplantation context.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!